You are here

Biblio

Search

Show only items where

Author

Type

Term

Year

Keyword

Export 5067 results:

Author Title Type [ Year

]

Filters: First Letter Of Last Name is M [Clear All Filters]

2019

Pennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, Burgess S, Willeit P, Bolton T, Moons KGM, et al. {Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. Eur Heart J. 2019 ;40:621–631.

Pennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, Burgess S, Willeit P, Bolton T, Moons KGM, et al. {Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. Eur Heart J. 2019 ;40:621–631.

Pennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, Burgess S, Willeit P, Bolton T, Moons KGM, et al. {Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies. Eur Heart J. 2019 ;40:621–631.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Flannick J, Mercader JM, Fuchsberger C, Udler MS, Mahajan A, Wessel J, Teslovich TM, Caulkins L, Koesterer R, Barajas-Olmos F, et al. {Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature. 2019 ;570:71–76.

Spracklen CN, Karaderi T, Yaghootkar H, Schurmann C, Fine RS, Kutalik Z, Preuss MH, Lu Y, Wittemans LBL, Adair LS, et al. {Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology. Am J Hum Genet. 2019 ;105:670–671.

Spracklen CN, Karaderi T, Yaghootkar H, Schurmann C, Fine RS, Kutalik Z, Preuss MH, Lu Y, Wittemans LBL, Adair LS, et al. {Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology. Am J Hum Genet. 2019 ;105:670–671.

Spracklen CN, Karaderi T, Yaghootkar H, Schurmann C, Fine RS, Kutalik Z, Preuss MH, Lu Y, Wittemans LBL, Adair LS, et al. {Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology. Am J Hum Genet. 2019 ;105:670–671.

Spracklen CN, Karaderi T, Yaghootkar H, Schurmann C, Fine RS, Kutalik Z, Preuss MH, Lu Y, Wittemans LBL, Adair LS, et al. {Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology. Am J Hum Genet. 2019 ;105:670–671.

Spracklen CN, Karaderi T, Yaghootkar H, Schurmann C, Fine RS, Kutalik Z, Preuss MH, Lu Y, Wittemans LBL, Adair LS, et al. {Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology. Am J Hum Genet. 2019 ;105:670–671.

Pages